It is a business services private limited company based in Allahabad, Uttar Pradesh, India, established in 2018.
2018 | Allahabad, Uttar Pradesh, India | ActiveRiedeli Pharmaceuticals Private Limited, a active private limited company, was established on 18 June 2018 in Allahabad, Uttar Pradesh, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999UP2018PTC105445. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Mohit Kumar Pandey (Director), Pallavi Pandey (Additional Director). Past directors included Chandra Prakash. It holds ₹0.65 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Dandi, Dandi Naini, Allahabad, Uttar Pradesh, 211008.
U74999UP2018PTC105445
105445
18 June 2018
₹0.50 M
₹0.50 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Riedeli Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mohit Kumar Pandey | Director | 18 Jun 2018 | Current |
| Pallavi Pandey | Additional Director | 05 Aug 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Jul 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Riedeli Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 27.79% decrease. The company also saw a substantial fall in profitability, with a 76.61% decrease in profit. The company's net worth moved up by a moderate rise of 1.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Riedeli Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹650,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jun 2020 | Others | ₹0.65 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Riedeli Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Riedeli Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riedeli Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Riedeli Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Riedeli Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
A charge with Others amounted to Rs. 0.65 M with Charge ID 100378325 was registered on 17 Jun 2020. was recorded as a recent event.
The activity Pallavi Pandey was appointed as a Additional Director was appointed as a Additional Director on 05 Aug 2019 & has been associated with this company since 6 years 4 months . was completed.
The activity Mohit Kumar Pandey was appointed as a Director was appointed as a Director on 18 Jun 2018 & has been associated with this company since 7 years 6 months . was completed.
The activity Riedeli Pharmaceuticals Private Limited was registered on 18 Jun 2018 with Roc Kanpur & aged 7 years 6 months as per MCA records. was completed.
The CIN of Riedeli Pharmaceuticals Private Limited is U74999UP2018PTC105445.
Riedeli Pharmaceuticals Private Limited is headquartered at Dandi, Dandi Naini, Allahabad, Uttar Pradesh, 211008.
Riedeli Pharmaceuticals Private Limited was incorporated on 18 June 2018.
The current directors of Riedeli Pharmaceuticals Private Limited are
The primary industry of Riedeli Pharmaceuticals Private Limited is Business Services.
Riedeli Pharmaceuticals Private Limited is unlisted.
The authorized capital of Riedeli Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX